Names & Terms You Will Hear
Plain-language meanings for the terms your care team may use.
| Term | Meaning |
|---|---|
| Lipoprotein(a) | Pronounced "L-P-little-a." A cholesterol-carrying particle similar to LDL but with an extra protein attached. |
| Lp(a) | Standard abbreviation. |
| LPA | The gene that codes for the apolipoprotein(a) protein. |
| Apo(a) or apolipoprotein(a) | The unique protein attached to Lp(a) that makes it pro-thrombotic and pro-inflammatory. |
| Inherited high cholesterol | Lp(a) is largely set by your DNA — not by diet. |
What Is Lipoprotein(a)?
- Lp(a) is a particle in your blood that looks like LDL (the 'bad' cholesterol) but carries an extra protein called apolipoprotein(a) — apo(a).
- That extra protein makes Lp(a) more likely to cause plaque buildup, promote clotting, and inflame the aortic valve.
- Your Lp(a) level is set largely by your genes. Lifestyle changes hardly move it. That's why it's a 'test once' lab in most cases.
- About 1 in 5 adults has elevated Lp(a). Most have never been tested.
- Elevated Lp(a) raises the risk of heart attack, stroke, and aortic stenosis, sometimes at younger ages than usual.
- A normal cholesterol panel does not include Lp(a). It must be ordered separately.
Why It Matters
- Lp(a) is one of the most common genetic causes of premature heart disease. It is missed in nearly everyone who doesn't get tested.
- Knowing your Lp(a) tells you whether you and your family should be more aggressive about other risk factors (LDL, blood pressure, diabetes, smoking).
- If you have a strong family history of heart attack, stroke, or aortic stenosis — especially at young ages — Lp(a) testing belongs on your workup.
- First-degree relatives (parents, siblings, children) of someone with elevated Lp(a) have a high chance of also being elevated. Family screening matters.
- New therapies are coming. Antisense and siRNA drugs (pelacarsen, olpasiran) can lower Lp(a) by 80-90% and are in pivotal trials. Knowing your Lp(a) now sets you up to benefit when these approve.
Risk Factors
Knowing your personal risks helps your care team take extra precautions.
| Risk Factor | Why It Increases Risk |
|---|---|
| Family history of early heart disease (men <55, women <65) | Strongest reason to test. Often inherited Lp(a) is the unrecognized driver. |
| Personal history of MI, stroke, or peripheral artery disease under 55 (men) or 65 (women) | Premature events should trigger Lp(a) testing. |
| Aortic valve calcification or aortic stenosis | Lp(a) is causally linked to aortic valve disease. |
| Recurrent cardiovascular events despite well-controlled LDL | Lp(a) is the most common 'residual risk' driver. |
| Severely elevated LDL or known familial hypercholesterolemia | Lp(a) elevation often coexists and compounds risk. |
| Black or South Asian ancestry | Average Lp(a) levels are higher; testing yield is higher. |
| Female sex after menopause | Lp(a) levels rise around menopause; risk profile changes. |
| Chronic kidney disease | Lp(a) is more often elevated and contributes more to risk. |
Treatment Options
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
- There is no FDA-approved Lp(a)-specific therapy yet. But several are in late-phase trials.
- Lower LDL aggressively. Statins, ezetimibe, bempedoic acid, and PCSK9 inhibitors don't lower Lp(a) much, but lowering LDL still reduces overall cardiovascular events.
- PCSK9 inhibitors (alirocumab, evolocumab) lower Lp(a) ~20-30% on top of their LDL effect.
- Niacin lowers Lp(a) modestly but is rarely used because of side effects and lack of outcome benefit in trials.
- Lipoprotein apheresis — a dialysis-like procedure — is FDA-approved for severe Lp(a)-driven progressive disease in select patients.
- Emerging: pelacarsen (antisense, weekly injection, Lp(a) HORIZON trial) and olpasiran (siRNA, every-12-weeks, OCEAN(a) trial) can lower Lp(a) by 80-90%.
- Aspirin: low-dose aspirin may be considered in elevated Lp(a) for primary prevention — discuss with your doctor; balance with bleeding risk.
- Lifestyle: diet and exercise don't lower Lp(a) much, but they reduce LDL, blood pressure, and weight — all of which matter when Lp(a) is high.
Risks, Benefits, and Alternatives
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
Every choice has trade-offs. Use this table to start the shared decision conversation with your care team.
| Option | Risks | Benefits | Alternatives |
|---|---|---|---|
| Get tested once | Out-of-pocket cost if insurance does not cover (~$30-100); psychological burden of high result. | Lifetime knowledge. Risk stratifies you and your family. Lets you and your doctor target aggressive control of other risk factors. | No test (status quo). |
| Aggressive LDL lowering when Lp(a) is high | Statin side effects (myalgias, mild glucose rise, rare myopathy); PCSK9 cost. | Reduces overall cardiovascular events even though LDL therapies barely move Lp(a) itself. | Standard LDL targets; lifestyle-only. |
| Lipoprotein apheresis | Time-intensive (every 1-2 weeks); cost; vascular access issues. | Lowers Lp(a) ~75% per session. FDA-approved for severe progressive disease. | Wait for emerging therapies; aggressive medication-based LDL lowering. |
| Enter a clinical trial of an Lp(a) lowering drug | Randomization (may receive placebo); unknown long-term side effects. | Access to therapies that may lower Lp(a) 80-90%; contribute to evidence base. | Wait for FDA approval; standard prevention. |
Common Misconceptions
| Myth | Reality |
|---|---|
| "My cholesterol panel was normal so Lp(a) must be fine." | Standard panels do NOT include Lp(a). It must be ordered specifically. |
| "I can lower my Lp(a) with diet." | Diet has very little effect. Lp(a) is largely genetic. |
| "There's no treatment so why would I test?" | Knowing changes how aggressively you and your doctor target OTHER risk factors. And new therapies are coming. |
| "My statin lowers my Lp(a)." | Statins lower LDL well but barely change Lp(a) (and may slightly raise it). PCSK9 inhibitors lower it more. |
| "If my Lp(a) is high, I'll definitely have a heart attack." | Elevated Lp(a) raises risk but is not a death sentence. Aggressive control of LDL, BP, weight, and smoking dramatically reduces risk. |
| "I should retest my Lp(a) every year." | Lp(a) is largely stable over your lifetime. Most adults only need it tested once. |
Possible Complications
Knowing what can go wrong helps you spot problems early. Most complications are uncommon, especially with treatment.
| Where / What | What Can Happen |
|---|---|
| Heart attack at younger ages | Lp(a) accelerates coronary plaque and clotting. |
| Ischemic stroke | Same biology; Lp(a) raises stroke risk independent of LDL. |
| Aortic stenosis | Lp(a) is causally linked to calcium buildup on the aortic valve. |
| Peripheral artery disease | Atherosclerosis in legs and beyond. |
| Recurrent events despite "good" cholesterol numbers | Lp(a) is the most common driver of residual risk in well-treated patients. |
| Family clusters of premature heart disease | If one relative is high, others likely are too — and missing this is a missed prevention opportunity. |
Points to Know
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you remember nothing else, remember these key points.
- Lp(a) is genetic — "test once, know forever" in most cases.
- About 1 in 5 adults has elevated Lp(a). Most have never been tested.
- A normal cholesterol panel does NOT measure Lp(a). You must ask for it.
- There is no FDA-approved Lp(a)-specific drug yet, but pelacarsen and olpasiran are in pivotal trials.
- If yours is high, aggressively control LDL, blood pressure, diabetes, and stop smoking.
- Test first-degree relatives — they have a high chance of being elevated too.
- PCSK9 inhibitors lower Lp(a) ~20-30% as a bonus.
When to Call Us — and When to Call 911
Shown in English for your safety — this section is not automatically translated. Confirm with your doctor or call the office.
If you are not sure, call. We would rather hear from you twice than miss a real problem.
- Call 911 for chest pain, sudden severe headache, weakness on one side, difficulty speaking, or vision loss.
- Call our office to schedule Lp(a) testing if you haven't been tested.
- Call our office if a first-degree relative has elevated Lp(a) — you may benefit from testing.
- Call our office if you've had recurrent cardiovascular events despite a controlled LDL.
- Call our office to discuss eligibility for Lp(a) lowering clinical trials.
- Call our office if a new doctor wants to stop your statin or other lipid-lowering medication — we can discuss the right plan given your Lp(a).
Office: (727) 943-5200
Trusted Resources
Independent, evidence-based pages we recommend for deeper reading.
- Family Heart Foundation — Lp(a) — Patient-focused community + family screening tools.
- AHA Scientific Statement on Lp(a) — Definitive clinical overview.
- Mayo Clinic — Lp(a) — Plain-language overview.
- Lipoprotein(a) Foundation — Patient advocacy and education.
- ClinicalTrials.gov Lp(a) trials — Find Lp(a) lowering clinical trials in your area.
Sources Used to Build This Guide
- AHA Scientific Statement: Lp(a) and Cardiovascular Disease (2022) [Scientific Statement] — Definitive overview of Lp(a) biology, measurement, and risk.
- European Atherosclerosis Society Consensus Statement on Lp(a) (2022) [Consensus] — International consensus on testing thresholds, who to test, and management.
- Lp(a) HORIZON trial (pelacarsen) [Trial] — Ongoing pivotal RCT of antisense Lp(a) lowering — future-of-treatment context.
- OCEAN(a)-Outcomes trial (olpasiran) [Trial] — siRNA Lp(a) lowering trial — emerging therapies section.
- Family Heart Foundation — Lipoprotein(a) [Patient advocacy] — Patient-friendly resource with calculators and family-screening guidance.
- Mayo Clinic — Lipoprotein(a) [Patient education] — Plain-language definition and clinical context.
- Tsimikas S. A Test in Context: Lp(a). JACC 2017. [Review] — Pathobiology and clinical decision framework.
- Lp(a) Foundation (Family Heart Foundation) [Patient advocacy] — Family screening tools and education for patients with elevated Lp(a).
